{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:12:25Z","timestamp":1792131145876,"version":"4.4.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3,1]]},"DOI":"10.1093\/cid\/cit794","type":"journal-article","created":{"date-parts":[[2013,12,6]],"date-time":"2013-12-06T22:07:34Z","timestamp":1386367654000},"page":"736-745","source":"Crossref","is-referenced-by-count":349,"title":["Determinants of Mortality in a Combined Cohort of 501 Patients With HIV-Associated Cryptococcal Meningitis: Implications for Improving Outcomes"],"prefix":"10.1093","volume":"58","author":[{"given":"Joseph N.","family":"Jarvis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tihana","family":"Bicanic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Loyse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Namarika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse C.","family":"Nussbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicky","family":"Longley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conrad","family":"Muzoora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Phulusa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kabanda","family":"Taseera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Creto","family":"Kanyembe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mina C.","family":"Hosseinipour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemarie E.","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Direk","family":"Limmathurotsakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"van der Horst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Meintjes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabbar","family":"Jaffar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,12,6]]},"reference":[{"key":"key\n\t\t\t\t20170522092228_CIT794C1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1471-2334-10-67","article-title":"Adult meningitis in a setting of high HIV and TB prevalence: findings from 4961 suspected cases","volume":"10","author":"Jarvis","year":"2010","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20170522092228_CIT794C2","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa065711","article-title":"Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa","volume":"357","author":"Scarborough","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170522092228_CIT794C3","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1097\/00002030-200007070-00013","article-title":"Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients","volume":"14","author":"Hakim","year":"2000","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170522092228_CIT794C4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.ijid.2005.07.004","article-title":"Primary and opportunistic pathogens associated with meningitis in adults in Bangui, Central African Republic, in relation to human immunodeficiency virus serostatus","volume":"10","author":"Bekondi","year":"2006","journal-title":"Int J Infect Dis"},{"key":"key\n\t\t\t\t20170522092228_CIT794C5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1086\/588792","article-title":"High-dose amphotericin B with flucytosine for the treatment of cryptococcal meningitis in HIV-infected patients: a randomized trial","volume":"47","author":"Bicanic","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522092228_CIT794C6","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.jinf.2010.03.007","article-title":"Outcomes of cryptococcal meningitis in antiretroviral naive and experienced patients in South Africa","volume":"60","author":"Jarvis","year":"2010","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20170522092228_CIT794C7","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1086\/587667","article-title":"Outcomes of cryptococcal meningitis in Uganda before and after the availability of highly active antiretroviral therapy","volume":"46","author":"Kambugu","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522092228_CIT794C8","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","article-title":"Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS","volume":"23","author":"Park","year":"2009","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170522092228_CIT794C9","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1016\/S0140-6736(04)16301-0","article-title":"Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial","volume":"363","author":"Brouwer","year":"2004","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170522092228_CIT794C10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1086\/518607","article-title":"Fungal burden, early fungicidal activity, and outcome in cryptococcal meningitis in antiretroviral-naive or antiretroviral-experienced patients treated with amphotericin B or fluconazole","volume":"45","author":"Bicanic","year":"2007","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522092228_CIT794C11","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1086\/593194","article-title":"Dose response effect of high-dose fluconazole for HIV-associated cryptococcal meningitis in southwestern Uganda","volume":"47","author":"Longley","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522092228_CIT794C12","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1086\/649861","article-title":"Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi","volume":"50","author":"Nussbaum","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522092228_CIT794C13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/cid\/cir745","article-title":"Comparison of the early fungicidal activity of high-dose fluconazole, voriconazole, and flucytosine as second-line drugs given in combination with amphotericin B for the treatment of HIV-associated cryptococcal meningitis","volume":"54","author":"Loyse","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522092228_CIT794C14","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jinf.2011.10.014","article-title":"Short course amphotericin B with high dose fluconazole for HIV-associated cryptococcal meningitis","volume":"64","author":"Muzoora","year":"2011","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20170522092228_CIT794C15","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/QAD.0b013e328354b419","article-title":"A phase II randomised controlled trial adding oral flucytosine to high dose fluconazole, with short-course amphotericin B, for cryptococcal meningitis in Malawi","volume":"26","author":"Jackson","year":"2012","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170522092228_CIT794C16","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/QAD.0b013e3283536a93","article-title":"Adjunctive interferon-gamma immunotherapy for the treatment of HIV-associated cryptococcal meningitis: a randomized controlled trial","volume":"26","author":"Jarvis","year":"2012","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170522092228_CIT794C17","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1086\/604716","article-title":"Independent association between rate of clearance of infection and clinical outcome of HIV-associated cryptococcal meningitis: analysis of a combined cohort of 262 patients","volume":"49","author":"Bicanic","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522092228_CIT794C18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522092228_CIT794C19","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.4049\/jimmunol.174.3.1746","article-title":"IFN-gamma at the site of infection determines rate of clearance of infection in cryptococcal meningitis","volume":"174","author":"Siddiqui","year":"2005","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20170522092228_CIT794C20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/QAI.0b013e3181a56f2e","article-title":"Immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitis: a prospective study","volume":"51","author":"Bicanic","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170522092228_CIT794C21","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(10)60666-6","article-title":"Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes","volume":"376","author":"May","year":"2010","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170522092228_CIT794C22","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1093\/infdis\/jit099","article-title":"The phenotype of the cryptococcus-specific CD4+ memory T-cell response is associated with disease severity and outcome in HIV-associated cryptococcal meningitis","volume":"207","author":"Jarvis","year":"2013","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t20170522092228_CIT794C23","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.jinf.2011.09.002","article-title":"Large volume lumbar punctures in cryptococcal meningitis clear cryptococcal antigen as well as lowering pressure","volume":"63","author":"Wijewardana","year":"2011","journal-title":"J Infect"},{"key":"key\n\t\t\t\t20170522092228_CIT794C24","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/cid\/cir613","article-title":"Evaluation of a novel point-of-care cryptococcal antigen test on serum, plasma, and urine from patients with HIV-associated cryptococcal meningitis","volume":"53","author":"Jarvis","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522092228_CIT794C25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/cid\/cir379","article-title":"Evaluation of a newly developed lateral flow immunoassay for the diagnosis of cryptococcosis","volume":"53","author":"Lindsley","year":"2011","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522092228_CIT794C26","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1086\/597262","article-title":"Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa","volume":"48","author":"Jarvis","year":"2009","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522092228_CIT794C27","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/655143","article-title":"Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells\/microL who start HIV therapy in resource-limited settings","volume":"51","author":"Meya","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522092228_CIT794C28","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1086\/657405","article-title":"Cryptococcal antigen screening for patients initiating antiretroviral therapy: time for action","volume":"51","author":"Jarvis","year":"2010","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170522092228_CIT794C29","article-title":"Rapid advice: diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children.","author":"World Health Organization","year":"2011"},{"key":"key\n\t\t\t\t20170522092228_CIT794C30","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1056\/NEJMc1305981","article-title":"Combination antifungal therapy for cryptococcal meningitis","volume":"368","author":"Loyse","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170522092228_CIT794C31","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S1473-3099(13)70078-1","article-title":"Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries","volume":"13","author":"Loyse","year":"2013","journal-title":"Lancet Infect Dis"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/58\/5\/736\/17351665\/cit794.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T14:56:47Z","timestamp":1503413807000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article-lookup\/doi\/10.1093\/cid\/cit794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,6]]},"references-count":31,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2013,12,6]]},"published-print":{"date-parts":[[2014,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/cit794","relation":{},"ISSN":["1537-6591","1058-4838"],"issn-type":[{"value":"1537-6591","type":"electronic"},{"value":"1058-4838","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12,6]]}}}